Quantitative, Preclinical PET of Translocator Protein Expression in Glioma Using 18F-N-Fluoroacetyl-N-(2,5-Dimethoxybenzyl)-2-Phenoxyaniline-Reference-Cited by-同舟云学术

Quantitative, Preclinical PET of Translocator Protein Expression in Glioma Using 18F-N-Fluoroacetyl-N-(2,5-Dimethoxybenzyl)-2-Phenoxyaniline

Published:2010-12-13 Issue:1 Volume:52 Page:107-114
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Buck Jason R.,McKinley Eliot T.,Hight Matthew R.,Fu Allie,Tang Dewei,Smith Ralph Adam,Tantawy Mohammed Noor,Peterson Todd E.,Colvin Daniel,Ansari Mohammed Sib,Baldwin Ronald M.,Zhao Ping,Guleryuz Saffet,Manning H. Charles

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference28 articles.

1. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

2. Regulation of translocator protein 18kDa (TSPO) expression in health and disease states☆

3. Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer;Maaser;Clin Cancer Res.,2002

4. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas;Pirotte;J Nucl Med.,2004

5. Increase in ?3 (Peripheral-Type Benzodiazepine) binding site densities in different types of human brain tumours

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal [18F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model;Biomedicines;2022-03-22

2. Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas;European Journal of Nuclear Medicine and Molecular Imaging;2021-04-13

3. Imaging of the glioma microenvironment by TSPO PET;European Journal of Nuclear Medicine and Molecular Imaging;2021-03-15

4. A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma;Theranostics;2021

5. Synthesis and pharmacological evaluation of [18F]PBR316: a novel PET ligand targeting the translocator protein 18 kDa (TSPO) with low binding sensitivity to human single nucleotide polymorphism rs6971;RSC Medicinal Chemistry;2021